Testing COVID-19 or pneumonia treatments in hospitalized patients
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized
- Doctors think you have pneumonia or pneumonia-like lung disease
- The cause is one of these: confirmed influenza A/B (possibly with COVID-19) or community-acquired pneumonia needing antibiotics
- Doctors believe other causes (like heart failure) are unlikely
- There is no major medical condition that would make joining too risky, in the clinician’s opinion
- You are not being treated mainly for certain other infections like tuberculosis or PCP (a specific lung fungal infection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new testing method (HCAP-Pcr) for people with pneumonia caught in the hospital or other healthcare settings. Doctors will use a special lung washing procedure called bronchoalveolar lavage to quickly identify the cause of the infection, which could help guide treatment faster.
This trial tests whether high-dose vitamin C given through an IV can improve outcomes in people with severe pneumonia. It may help your body fight infection and reduce complications, but it also has several safety checks.
This Phase 2 trial tests an investigational medicine (given in increasing doses) for hospitalized people with pneumonia who need supplemental oxygen. It aims to see if the medicine is safe and potentially helps the pneumonia process in the early hospital period.
This study looks at how well different treatments work for people with lung infections or sudden worsening of chronic lung disease. If you have a respiratory sample available and are about to start an antibiotic, antiviral, antifungal, or steroid, you may be able to join.
This trial looks at whether taking certain diabetes medications (GLP-1 agonists or SGLT2 inhibitors) before being hospitalized for pneumonia can improve early recovery in adults with type 2 diabetes. It compares these drugs to standard diabetes treatments.
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.